NCT03974659

Brief Summary

At present, the incidence of language dysfunction in patients with brain language area tumor in the first month after operation was 20%-40%. The investigator's team has confirmed and found that bilateral cerebellar VIIa lobules are the critical areas of cerebellar which is closely related to the language function of the patients. This study aims at enhancing language function recovery after surgery through the transcranial magnetic stimulation stimulates the key areas of cerebellar. This study is a prospective, randomized, double-blind, multi-center clinical trial in which participants with postoperative aphasia in the brain-language region tumors of three neurosurgery departments, Huashan Hospital, Shanghai Jing'an Center Hospital and Huashan Hospital North Hospital. Participants were randomly divided into Intervention group and control group. Before transcranial magnetic stimulation treatment, the two groups were required to conduct language behavior assessment and magnetic resonance imaging data. Participants in both groups were given 10 consecutive days bilateral cerebellar VIIa lobules Theta Burst Stimulation from one week after surgery and received speech rehabilitation training after stimulation. The investigators collect patients MRI data and language behavioral assessment scores at 1week post operation and 1 month after the operation and 3 months after the operation. Subsequently, three MRI data and language behavioral assessment scores were processed and statistically analyzed to compare the differences between the two groups

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2021

Completed
Last Updated

June 5, 2019

Status Verified

October 1, 2018

Enrollment Period

2.5 years

First QC Date

May 20, 2019

Last Update Submit

June 2, 2019

Conditions

Outcome Measures

Primary Outcomes (6)

  • Boston naming test

    The change of Boston naming test scores is being assessed

    Change from postoperative 1 week to postoperative 1month & postoperative 3 months

  • MMSE

    The change of Mini-mental State Examination scores is being assessed

    Change from postoperative 1 week to postoperative 1month & postoperative 3 months

  • ABC

    Aphasia Battery of Chinese,Conclude naming, repeating, comprehend and spontaneous speech test,The change of ABC scores is being assessed

    Change from postoperative 1 week to postoperative 1month & postoperative 3 months

  • ALFF

    The change of Cerebellar spontaneous neurological activity level is being assessed

    Change from postoperative 1 week to postoperative 1month & postoperative 3 months

  • Cerebellar gray matter volume

    The change of Cerebellar gray matter volume is being assessed

    Change from postoperative 1 week to postoperative 1month & postoperative 3 months

  • Functional connectivity of cerebellar network

    The change of functional connectivity of cerebellar network is being assessed

    Change from postoperative 1 week to postoperative 1month & postoperative 3 months

Study Arms (2)

Theta Burst Stimulation

ACTIVE COMPARATOR

Intervention group: ten consecutive days bilateral cerebellar VIIa lobules Theta Burst Stimulation. Intermittent Theta Burst Stimulation(Positive stimulation) is used in right cerebellar VIIa lobule.Each stimulus had three 50 Hz monopulses, which were repeated every 200 ms. Each stimulation continued for 2 seconds and rested for 8 seconds. The total intervention time was 200s (600 pulses) Continuous Theta Burst Stimulation(Negative stimulation) is used in left cerebellar VIIa lobule,three 50 Hz monopulses in each stimulus, each with an interval of 200 ms, and each intervention lasted 40s (600 pulses). The stimulation intensity was 80% Rest Motor Threshold.According to the patients' condition, age and tolerance,the intensity should be adjusted.

Combination Product: Transcranial magnetic stimulation

sham Theta Burst Stimulation

SHAM COMPARATOR

sham group: we flip coil to make fake stimulation, the stimulation will also make sounds, but no magnetic field effect, the stimulation mode is the same as the intervention group.

Combination Product: Transcranial magnetic stimulation

Interventions

1.Patients were given 10 consecutive days bilateral cerebellar VIIa lobules Theta Burst Stimulation which was a special mode of Transcranial magnetic stimulation from one week after surgery Intermittent Theta Burst Stimulation(Positive stimulation) is used in right cerebellar VIIa lobule.Each stimulus had three 50 Hz monopulses, which were repeated every 200 ms. Each stimulation continued for 2 seconds and rested for 8 seconds. The total intervention time was 200s (600 pulses) Continuous Theta Burst Stimulation(Negative stimulation) is used in left cerebellar VIIa lobule,three 50 Hz monopulses in each stimulus, each with an interval of 200 ms, and each intervention lasted 40s (600 pulses).

Also known as: speech rehabilitation training
Theta Burst Stimulationsham Theta Burst Stimulation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Language dysfunction after brain tumor surgery (aphasia quotient,AQ)\< 93.8
  • Chinese mother tongue
  • Right handedness confirmed by Edinburgh Handedness Scale
  • Tumor patients with linguistic region involvement in the dominant hemisphere
  • Karnofsky Performance Status (KPS)\< 70
  • Voluntary participation in this project

You may not qualify if:

  • Patients with frequent epileptic seizures (\> 2 epilepsy episodes per week)
  • Previous implants of metal pacemakers, stimulators, hearing aids, dentures, and insulin pumps or claustrophobia
  • People with a history of psychiatric disorders
  • Patients with severe medical diseases
  • Patients with Alzheimer's disease and Parkinson's disease. Medical diseases
  • Pregnant women
  • Other clinical trials in the same period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Huashan Hospital Affiliated to Fudan University

Shanghai, Shanghai Municipality, 200040, China

RECRUITING

Shanghai Jing'an Central Hospital

Shanghai, Shanghai Municipality, 200040, China

RECRUITING

MeSH Terms

Conditions

Language Disorders

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Communication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Jinsong Wu, MD

    Huashan Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jinsong Wu, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A Prospective Randomized, Double-Blind Clinical Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

May 20, 2019

First Posted

June 5, 2019

Study Start

October 30, 2018

Primary Completion

April 30, 2021

Study Completion

October 30, 2021

Last Updated

June 5, 2019

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations